Jul 26, 2021 04:14 PM (GMT+8) · EqualOcean
Beilu pharmaceutical announced that recently, the company received the notice of approval of drug supplementary application (Notice No.: 2021b02267 and 2021b02268) on two specifications of meglumine gadolinate injection issued by the State Drug Administration. The drug passed the consistency evaluation of generic drug quality and efficacy.